Screening for gastric cancer: East and West, features of diagnostic criteria
https://doi.org/10.31146/1682-8658-ecg-181-9-73-78
Abstract
Gastric cancer is the leading cause of death among all cancer deaths. Identification of risk groups and special carcinogens will prevent the development of the tumor or detect it in the early stages, which will significantly increase the quality of life of patients with high risks of developing gastric cancer. For the timely detection of tumor development, it is optimal to use systematic screening. Undoubtedly, the approaches to the diagnosis of cancer have significant differences in the countries of the West and the East.
About the Authors
A. A. Avanesyan
Federal budget healthcare institution “St. Petersburg clinical scientifi c and practical center for specialized types of medical care (oncology)”; Federal State budget institution “N. N. Petrov national medical research center of oncology” of the ministry of healthcare of the Russian Federation
Russian Federation
Russian Federation
Albina A. Avanesyan, MD, PhD, chief of endoscopy department in Saint-Petersburg scientifi cal practical center of specialized kinds of medical care (oncological)
197758, St. Petersburg, Pesochny, st. Leningradskaya, 68A, lit. A
197758, St. Petersburg, Pesochny, st. Leningradskaya, 68
O. V. Chukina
Federal State budget institution “N. N. Petrov national medical research center of oncology” of the ministry of healthcare of the Russian Federation
Russian Federation
Russian Federation
Olga V. Chukina, MD, PhD, endoscopy department in Saint-Petersburg scientifi cal practical center of specialized kinds of medical care (oncological)
197758, St. Petersburg, Pesochny, st. Leningradskaya, 68
Yu. V. Kokovina
Federal State budget institution of higher education “Northwest State Medical University named after I. I. Mechnikov” of the Russian Federation Ministry of Health
Russian Federation
Russian Federation
Yuliya V. Kokovina, Cand. of Med. Sci., assistant of the Department of Propaedeuticucs of internal Diseases, Gastroenterology and Dietetics
191015, St. Petersburg, Kirochnaya st., 41
T. M. Chirkina
Federal State budget institution of higher education “Northwest State Medical University named after I. I. Mechnikov” of the Russian Federation Ministry of Health
Russian Federation
Russian Federation
Tatiyana M. Chirkina, Cand. of Med. Sci., assistant of the department of Epidemiology
191015, St. Petersburg, Kirochnaya st., 41
I. G. Bakulin
Federal State budget institution of higher education “Northwest State Medical University named after I. I. Mechnikov” of the Russian Federation Ministry of Health
Russian Federation
Russian Federation
Igor G. Bakulin, MD, PhD, Professor, Head of the Department of Propaedeuticucs of internal Diseases, Gastroenterology and Dietetics
191015, St. Petersburg, Kirochnaya st., 41
References
1. Lansdorp-Vogelaar I., Kuipers E. J. Screening for gastric cancer in Western countries. Gut, 2016, no. 65, pp. 543–544. doi: 10.1136/gutjnl-2015–310356
2. Kim B. J., Heo Ch., Kim B. K. et al. Effectiveness of gastric cancer screening programs in South Korea: organized vs opportunistic models. World J Gastroenterol, 2013, no. 19, pp. 736. doi: 10.3748/wjg.v19.i5.736
3. Kitagawa S., Miyagawa K., Iriguchi Y. et al. The report of gastroenterological screening in 2012. J Gatsroenterol Cancer Screen, 2015, no. 53, pp. 60–86.
4. Comparison of 5 year’s survival rates between Japan and Western countries. Cancer Statistics in Japan, 2006, 59 p.
5. Choi K. S. Jun J. K., Suh M. et al. Effect of endoscopy screening on stage at gastric cancer diagnosis: results of the National Cancer Screening Programme in Korea. Br J Cancer, 2015, no. 112, pp. 608. doi: 10.1038/bjc.2014.608
6. Hyun A. P., Su Y. N., Sang K. L. et al. The Korean guideline for gastric cancer screening. Journal of the Korean Medical Association, 2015, no. 58, pp. 373–384. doi: 10.5124/jkma.2015.58.5.373
7. Schlemper R. J., Itabashi M., Kato Y. et al. Differences in diagnostic criteria for gastric carcinoma between Japanese and Western pathologists. The Lancet, 1997, no. 349, pp. 1725–1729. doi: 10.1016/S0140–6736(96)12249–2
8. Qiong Chen, Liang Yu, Chang-qing Hao et al. Effectiveness of endoscopic gastric cancer screening in a rural area of Linzhou, China: results from a case–control study. Cancer Medicine, 2016, no. 5, pp. 2615–2622. doi: 10.1002/cam4.812
9. Hamashima C., Ogoshi K., Okamoto M. et al. Mortality reduction from gastric cancer by endoscopic and radiographic screening. Cancer Science. 2015, Vol. 06, pp. 1744–1749. doi: 10.1111/cas.12829
10. Hamashima C., Fukao A. Quality assurance manual of endoscopic screening for gastric cancer in Japanese communities. Jpn J Clin Oncol,.2016, no. 46, pp. 1053–1061. doi: 10.1093/jjco/hyw106
11. Cho Y. K. How to improve the quality of screening endoscopy in Korea: national endoscopy quality improvement program? Clin Endosc, 2016, no. 49, pp. 312. doi: 10.5946/ce.2016.084
12. Asaka M., Kato M., Sakamoto N. Roadmap to eliminate gastric cancer with Helicobacter pylori eradication and consecutive surveillance in Japan. Journal Gastroenterol, 2014, no. 49, pp. 1–8. doi: 10.1007/s00535–013–0897–8
13. Asaka M. A new approach for elimination of gastric cancer deaths in Japan. Int J Cancer, 2013, no. 132, pp. 1272–1276. doi: 10.1002/ijc.27965
14. Hyuk Y., Nayoung K., Hye S. L. et al. Effect of endoscopic screening at 1-year intervals on the clinicopathologic characteristics and treatment of gastric cancer in South Korea. J Gastroenterol Hepatol, 2012, no. 27, pp. 928–934. doi: 10.1111/j.1440–1746.2011.07038.x
15. Hosokawa O., Hattori M., Takeda T. et al. Accuracy of endoscopy in detecting gastric cancer. J. Gastroenterol Mass. Surv, 2004, no.42, pp.33–39.
16. Iskusstvennyj intellekt pomozhet v rannej diagnostike raka zheludka (2019) Available at: https://techfusion.ru/iskusstvennyj-intellekt-pomozhet-v-rannej-diagnostike-raka-zheludka/ (accessed 14 April 2020)
17. Matsumoto S., Ishikawa S., Yoshida Y. Reduction of gastric cancer mortality by endoscopic and radiographic screening in an isolated island: A retrospective cohort study. Australian Journal of Rural Health, 2013, no. 21, pp. 319–324. doi: 0.1111/ajr.12064
18. Nam, J.H., Choi I. J., Cho S. J. et al. Association of the interval between endoscopies with gastric cancer stage at diagnosis in a region of high prevalence. Cancer, 2012, no. 118, pp. 4953–4960. doi: 10.1002/cncr.27495
19. Yeh J. M., Hur C., Ward Z., et al. Gastric adenocarcinoma screening and prevention in the era of new biomarker and endoscopic technologies: a cost-effectiveness analysis. Gut, 2016, no. 65, pp. 563–574. doi: 10.1136/gutjnl-2014–308588
20. Cancer facts & figures (2020) Available at https://www.cancer.org/research/cancer-facts-statistics/all-cancerfacts-figures/cancer-facts-figures-2020.html (accessed 10 April 2020).
21. Gastric Cancer. Available at: https://emedicine.medscape.com/article/278744-overview#a1 (accessed 13 April 2020)
22. National Cancer Center. Cancer Facts & Figures 2015 in the Republic of Korea, 1st edn Gyeonggi-do. Minister for Health and Welfare, 2015.
23. Promotion of evidence based cancer screening. National Cancer Center. Japan: The Japanese guidelines for gastric cancer screening (2015). Available at: http://canscreen.ncc.go.jp/ (accessed 15 February 2016).
24. Asaka M., Mabe K. Strategies for eliminating death from gastric cancer in Japan. Proceedings of the Japan Academy, 2014, no. 90, pp. 251–258. doi: 10.2183/pjab.90.251
25. Бондарь Г. В., Думанский Ю. В., Попович А. Ю. и др. Современные возможности диагностики и лечения рака желудка // Онкология – 2012. – Т. 14. – № . 2. – С. 89–92 Bondar G. V., Dumansky Yu.V., Popovich A. Yu. et. al. Modern possibilities for the diagnosis and treatment of gastric cancer. Oncology, 2012; vol.14, no. 2, pp. 89–92
26. Bondar G. V., Dumansky Yu.V., Popovich A. Yu. et. al. Modern possibilities for the diagnosis and treatment of gastric cancer. Oncology. 2012:14(2): 89–92
27. SEER Cancer Statistics Review, 1975–2011, National Cancer Institute. Bethesda, MD. – 2015. Available at: https://seer.cancer.gov/archive/csr/1975_2011/#contents (accessed 10 April 2020)
28. Ferlay J., Shin H. R., Bray F. et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN2008. Int J Cancer, 2010, no. 127, pp. 2893–2917. doi: 10.1002/ijc.25516
29. PDQ® Screening and prevention editorial board. PDQ stomach (gastric) cancer screening. Available at: https://www.cancer.gov/types/stomach/patient/stomach-screening-pdq (accessed 10 March 2020)
30. Waddell T. et al. Gastric cancer: ESMO–ESSO–ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology, 2013, no. 24, pp. vi57-vi63. doi: 0.1093/annonc/mdt344
31. Hamashima C. et al. A community-based, case-control study evaluating mortality reduction from gastric cancer by endoscopic screening in Japan. PLoS One, 2013, no. 8, pp. e79088. doi: 10.1016/j.jval.2013.08.417
32. Thrumurthy S. G., Chaudry M. A., Hochhauser D. et al. The diagnosis and management of gastric cancer. BMJ, 2013, no. 347, pp. f6367. DOI: 10.1136/bmj.f6367
33. National Cancer Center. The Japanese guidelines for gastric cancer screening 2014. Promotion of evidence-based cancer screening, 2016.
34. Lu Y. F., Lui Z. C., Li Z. H. et al. Esophageal/gastric cancer screening in high-risk populations in Henan Province, China. Asian Pac J Cancer Prev, 2014, no. 15, pp. 1419– 1422. doi: 10.7314/apjcp.2014.15.3.1419
35. Yaponskij iskusstvennyj intellekt diagnostiruet rak kishechnika za 1 sekundu (2017). Available at: https://hightech.fm/2017/10/31/ai-japan?is_ajax=1 (accessed 14 April 2020)
36. Cancer statistics in Japan (2017) Available at https://ganjoho.jp/en/professional/statistics/brochure/2017_en.html (accessed 10 April 2020).
37. GLOBOCAN2012: estimated cancer incidence, mortality and prevalence worldwide in 2012. Available at: https://publications.iarc.fr/Databases/IarcCancerbases/GLOBOCAN-2012-Estimated-CancerIncidence-Mortality-And-Prevalence-WorldwideIn-2012-V1.0-2012 (accessed 14 April 2020)
38. Avital I., Pisters P. W.T., Kelsen D. P. et al. Cancer of the stomach, In: DeVita Cancer: principles & practice of oncology. Lippincott Williams & Wilkins, 2011. doi: 10.1001/jama.1997.03550100097049
39. Choi K. S., Jun J. K., Suh M. et al. Performance of different gastric cancer screening methods in Korea: a population-based study. PLoS One, 2012, no. 7, pp. e50041. doi: 10.1371/journal.pone.0050041
40. Hamashima C ., Okamoto M., Shabana M. et al. Sensitivity of endoscopic screening for gastric cancer by the incidence method. Int J Cancer, 2013, no. 133, pp. 653–659. doi: 10.1002/ijc.28065
41. Evaluation of the validity of current national health screening program and plan to improve the system. Cheongju: Korea Centers for Disease Control and Prevention. Available at: https://www.scienceopen.com/document?vid=d0b8c597-fce9-49cc-8084-da4a94358dd2 (accessed 10 April 2020)
42. Cha J. M. Quality improvement of gastrointestinal endoscopy in Korea: past, present, and future. Korean J Gastroenterol, 2014, no. 64, pp. 320–332. doi: 10.4166/kjg.2014.64.6.320
43. Hamashima C., Goto R. Potential capacity of endoscopic screening for gastric cancer in Japan. Cancer Science, 2017, no. 108, pp. 101–107. doi: 10.1111/cas.13100
Review
For citations:
Avanesyan A.A., Chukina O.V., Kokovina Yu.V., Chirkina T.M., Bakulin I.G. Screening for gastric cancer: East and West, features of diagnostic criteria. Experimental and Clinical Gastroenterology. 2020;(9):73-78. (In Russ.) https://doi.org/10.31146/1682-8658-ecg-181-9-73-78
Views:
482
Email this article 